Zoghbi Huda Y 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2026/2/23 申報
- 申報編號
- 0001681643-26-000004
- 申報時間
- 2026/2/23
- 交易日
- 2026/2/19
- 申報延遲
- 4 天
- 10b5-1 計畫
- 有勾選
這份申報列了 12 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $128.0 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Zoghbi Huda YCIK 0001681643 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/2/19 | Common Stock | M行使選擇權取得 | +1,638 | $376.69 | +$617,018.22 | 3,341 | 直接 | |
| 2026/2/19 | Common Stock | S賣出處分 | −49 | $774.68 | −$37,959.32 | 3,292 | 直接 | |
| 2026/2/19 | Common Stock | S賣出處分 | −50 | $775.50 | −$38,775 | 3,242 | 直接 | |
| 2026/2/19 | Common Stock | S賣出處分 | −53 | $778.47F2 | −$41,258.91 | 3,189 | 直接 | |
| 2026/2/19 | Common Stock | S賣出處分 | −208 | $779.55F3 | −$162,146.4 | 2,981 | 直接 | |
| 2026/2/19 | Common Stock | S賣出處分 | −331 | $780.45F4 | −$258,328.95 | 2,650 | 直接 | |
| 2026/2/19 | Common Stock | S賣出處分 | −209 | $781.28F5 | −$163,287.52 | 2,441 | 直接 | |
| 2026/2/19 | Common Stock | S賣出處分 | −298 | $782.10F6 | −$233,065.8 | 2,143 | 直接 | |
| 2026/2/19 | Common Stock | S賣出處分 | −220 | $783.29F7 | −$172,323.8 | 1,923 | 直接 | |
| 2026/2/19 | Common Stock | S賣出處分 | −160 | $784.45F8 | −$125,512 | 1,763 | 直接 | |
| 2026/2/19 | Common Stock | S賣出處分 | −56 | $785.61F9 | −$43,994.16 | 1,707 | 直接 | |
| 2026/2/19 | Common Stock | S賣出處分 | −4 | $790.00 | −$3,160 | 1,703 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/2/19 | Common Stock | M行使選擇權處分 | −1,638 | $0.00 | $0 | 800 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
Represents volume-weighted average price of sales of 53 shares of Company stock on February 19, 2026 at prices ranging from $778.46 to $778.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 208 shares of Company stock on February 19, 2026 at prices ranging from $779.10 to $779.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 331 shares of Company stock on February 19, 2026 at prices ranging from $780.06 to $780.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 209 shares of Company stock on February 19, 2026 at prices ranging from $781.10 to $781.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 298 shares of Company stock on February 19, 2026 at prices ranging from $782.01 to $782.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
Represents volume-weighted average price of sales of 220 shares of Company stock on February 19, 2026 at prices ranging from $783.00 to $783.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
Represents volume-weighted average price of sales of 160 shares of Company stock on February 19, 2026 at prices ranging from $784.14 to $784.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F9
Represents volume-weighted average price of sales of 56 shares of Company stock on February 19, 2026 at prices ranging from $785.60 to $785.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。